• Save
Orbomed - office based hysteroscopy
Upcoming SlideShare
Loading in...5
×
 

Orbomed - office based hysteroscopy

on

  • 609 views

 

Statistics

Views

Total Views
609
Views on SlideShare
609
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Orbomed - office based hysteroscopy Orbomed - office based hysteroscopy Presentation Transcript

  • OrbomedEARLY DIAGNOSIS – TIMELY CURE
  • Orbomed teamVitaly Vishnepolsky, MBA CEO Dr. Vadim Sigalov, MDChief Business consultant Chief Medical consultant Ksenia Chagan, MBA Igor Shcherback, PhD Biotech advisor Physics advisor
  • Hysteroscopy: background• Gold standard for detection of intrauterine pathology• Safe and simple procedure for outpatient clinics
  • Hysteroscopy: background (cont.)• From patients’ side pain continues to represent the main limiting factor to a large-scale use of outpatient hysteroscopy
  • Office Based Hysteroscopy(OBH) facts• Only 15% of gynecologists in the United States routinely perform office hysteroscopy to evaluate intrauterine pathology. Reimbursement Equipment
  • The OBH need• Broadening of applications’ list• Cost reduction• Becoming the gold standard for specific operations• Updating of reimbursement policies.
  • Orbomed:Office Based Hysteroscopy product line• Three dimensional scissors• No need for laparoscop reposition• Easier lesion capture in moving media (saline flow)• Ready-for-sending tissue sample post-operationally
  • What is the difference inORBOMED concept?VIDEO>>
  • Advantages of Orbomed• Improved patient’s comfort• Eliminated need for general anesthesia• Shorten interventional procedure• Reduced overall cost
  • Target CustomersPrivate/public gynecological clinics
  • Applications• Polypectomy – 6M of annual visits• Adhesiolysis – 1M of Asherman Syndrome• Biopsy under direct visualization – approx. 50K of new endometrial cancer/year
  • Market potential• Global Uro-Gynecological Surgical Devices Market to Reach US$1.98 Billion by 2015• Global Biopsy devices Market is expected to reach $1.4 Billion by 2018, CAGR 5% from 2011.
  • Orbomed R&D plan• Within 24 months we plan to achieve fully working prototype ready for clinical trials• Planned budget $750K
  • ‫‪Budget‬‬ ‫שיווק‬ ‫שונות‬ ‫%9‬ ‫ציוד‬ ‫%31‬ ‫שכר‬ ‫%3‬ ‫%24‬ ‫קבלני משנה‬ ‫%92‬ ‫חומרים וציוד‬ ‫מתכלה‬ ‫%4‬
  • Thank you